Semaglutide - From Diabetes to Weight Management: An Overview for Pharmacy Technicians

About 422 million people worldwide have diabetes and 1.2 million Americans are diagnosed with diabetes every year. In 2022, 1 in 8 people in the world were living with obesity. Obesity can lead to increased risk of type 2 diabetes and heart disease. In this session, the learner will be able to identify the efficacy of semaglutide for both type 2 Diabetes and weight loss. The most common adverse effects and contraindications of semaglutide will be examined. Compounded semaglutide has emerged in a broad way. This session will also examine the potential problems and regulatory parameters in this space.